Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Sarcoma and Bone Cancers January 2011 This twice-yearly bulletin covers sarcomas, soft tissue tumours and bone cancers, and should be of interest to multidisciplinary teams working in this area. Sections can include: Pathology, Polymorphisms & Biomarkers Prognosis, Incidence, Survival & Risk Factors Radiography & Imaging Symptom Management & Supportive Care Therapies Many of the following articles are available online via the NHS Scotland Knowledge Network. Please use the links where provided and your ATHENS password. A complete list of available online journals and registration for ATHENS can be found at www.knowledge.scot.nhs.uk/ If the article you require is not available via the NHS Scotland Knowledge Network and you would like to request a print copy, please submit your request online at www.quest.scot.nhs.uk This bulletin contains a selection of material gathered from a search of the evidence base, and is not intended to be comprehensive. Professional judgment should be exercised when appraising the material. The Library takes no responsibility for the wording, content and accuracy of the information supplied, which has been extracted in good faith from reputable sources. NHSGGC is not responsible for the content of external internet sites. Compiled by: Kirsty Coltart Specialist Librarian Beatson West of Scotland Cancer Centre 0141 301 7285, [email protected] 1 Sarcoma and Bone Cancers, January 2011 Kirsty Coltart, Specialist Librarian, NHSGGC Library Network General Arkader, A. and Dormans, J.P. (2010). Pediatric extremity soft-tissue sarcomas: From diagnosis to surgical treatment. Current Orthopaedic Practice 21,5:508-517. Coleman, R.E., Lipton, A., Roodman, G.D., et al. (2010). Metastasis and bone loss: advancing treatment and prevention. Cancer treatment reviews 36,8:615-620. Ferguson, P.C., Deheshi, B.M., Chung, P., et al. (2011). Soft tissue sarcoma presenting with metastatic disease. Cancer 117,2:372-379. Ritter, J. and Bielack, S.S. (2010). Osteosarcoma. Annals of Oncology 21,SUPPL. 7:320325. Woodward, E.J. and Coleman, R.E. (2010). Prevention and treatment of bone metastases. Current pharmaceutical design 16,27:2998-3006. Wright, J. and Schiffman, J.D. (2011). Ewing's sarcoma and second malignancies. Sarcoma 2011, Combined Modality Therapies Kraybill, W.G., Harris, J., Spiro, I.J., et al. (2010). Long-term results of a phase 2 study of neoadjuvant chemotherapy and radiotherapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514. Cancer 116,19:4613-4621. Munene, G., MacK, L.A. and Temple, W.J. (2011). Systematic review on the efficacy of multimodal treatment of sarcomatosis with cytoreduction and intraperitoneal chemotherapy. Annals of Surgical Oncology 18,1:207-213. Drug Therapy Aapro, M., Saad, F. and Costa, L. (2010). Optimizing clinical benefits of bisphosphonates in cancer patients with bone metastases. Oncologist 15,11:11471158. Assi, H., Missenard, G., Terrier, P., et al. (2010). Intensive induction chemotherapy without methotrexate in adult patients with localized osteosarcoma: Results of the Institut Gustave-Roussy phase II trial. Current Oncology 17,6:23-31. Chugh, R., Wathen, J.K., Patel, S.R., et al. (2010). Efficacy of imatinib in aggressive fibromatosis: Results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) trial. Clinical Cancer Research 16,19:4884-4891. Coleman, R., Cook, R., Hirsh, V., et al. (2011). Zoledronic acid use in cancer patients. Cancer 117,1:11-23. Kroep, J.R., Ouali, M., Gelderblom, H., et al. (2011). First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: An EORTC Soft Tissue and Bone Sarcoma Group study. Annals of Oncology 22,1:207-214. 2 Sarcoma and Bone Cancers, January 2011 Kirsty Coltart, Specialist Librarian, NHSGGC Library Network Mascarenhas, L., Lyden, E.R., Breitfeld, P.P., et al. (2010). Randomized phase II window trial of two schedules of irinotecan with vincristine in patients with first relapse or progression of rhabdomyosarcoma: a report from the Children's Oncology Group. Journal of Clinical Oncology 28,30:4658-4663. Moore, M. and Desai, J. (2010). New drugs in the management of sarcoma. Cancer Forum 34,3:157-163. Odri, G.A., Dumoucel, S., Picarda, G., et al. (2010). Zoledronic acid as a new adjuvant therapeutic strategy for Ewing's sarcoma patients. Cancer research 70,19:7610-7619. Padhye, B. and McCowage, G. (2010). Chemotherapy regimens in newly diagnosed and recurrent ewing sarcoma in children and young adults. Cancer Forum 34,3:131-137. Soini, E.J.O., Garcia San Andres, B. and Joensuu, T. (2011). Trabectedin in the treatment of metastatic soft tissue sarcoma: Cost-effectiveness, cost-utility and value of information. Annals of Oncology 22,1:215-223. Stopeck, A.T., Lipton, A., Body, J.J., et al. (2010). Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. Journal of Clinical Oncology 28,35:5132-5139. Subbiah, V. and Anderson, P. (2011). Targeted therapy of Ewing's sarcoma. Sarcoma 2011, Syddall, S.P., Ottewell, P.D. and Holen, I. (2010). Combined therapies of bone disease with bisphosphonates. Current pharmaceutical design 16,27:2988-2997. Pathology, Polymorphisms & Biomarkers Huh, W.W. and Skapek, S.X. (2010). Childhood rhabdomyosarcoma: New insight on biology and treatment. Current oncology reports 12,6:402-410. Korpi, J.T., Hagstrom, J., Lehtonen, N., et al. (2011). Expression of matrix metalloproteinases-2, -8, -13, -26, and tissue inhibitors of metalloproteinase-1 in human osteosarcoma. Surgical oncology 20,1:e18-e22. Pinto, A., Dickman, P. and Parham, D. (2011). Pathobiologic markers of the Ewing sarcoma family of tumors: State of the art and prediction of behaviour. Sarcoma 2011, Santini, D., Galluzzo, S., Zoccoli, A., et al. (2010). New molecular targets in bone metastases. Cancer treatment reviews 36,Suppl 3:S6-S10. Zhou, Q., Zhu, Y., Deng, Z., et al. (2011). VEGF and EMMPRIN expression correlates with survival of patients with osteosarcoma. Surgical oncology 20,1:13-19. Prognosis, Incidence, Survival & Risk Factors Brown, J.E., Cook, R.J., Lipton, A., et al. (2010). Prognostic factors for skeletal complications from metastatic bone disease in breast cancer. Breast Cancer Research & Treatment 123,3:767-779. 3 Sarcoma and Bone Cancers, January 2011 Kirsty Coltart, Specialist Librarian, NHSGGC Library Network Puhaindran, M.E., Rohde, R.S., Chou, J., et al. (2011). Clinical outcomes for patients with soft tissue sarcoma of the hand. Cancer 117,1:175-179. Weber, M.H., Burch, S., Buckley, J., et al. (2011). Instability and impending instability of the thoracolumbar spine in patients with spinal metastases: A systematic review. International journal of oncology 38,1:5-12. Radiotherapy & Imaging Balliu, E., Boada, M., Pelaez, I., et al. (2010). Comparative study of whole-body MRI and bone scintigraphy for the detection of bone metastases. Clinical radiology 65,12:989-996. Blattmann, C., Oertel, S., Schulz-Ertner, D., et al. (2010). Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with nonresectable osteosarcoma. BMC Cancer 10,96. Costa, F.M., Ferreira, E.C. and Vianna, E.M. (2011). Diffusion-weighted magnetic resonance imaging for the evaluation of musculoskeletal tumors. Magnetic resonance imaging clinics of North America 19,1:159-180. Dickie, C.I., Parent, A.L., Chung, P.W., et al. (2010). Measuring interfractional and intrafractional motion with cone beam computed tomography and an optical localization system for lower extremity soft tissue sarcoma patients treated with preoperative intensity-modulated radiation therapy. International journal of radiation oncology, biology, physics 78,5:1437-1444. Nikoghosyan, A.V., Karapanagiotou-Schenkel, I., Munter, M.W., et al. (2010). Randomised trial of proton vs. carbon ion radiation therapy in patients with chordoma of the skull base, clinical phase III study HIT-1-Study. BMC Cancer 10, Rades, D. and Abrahm, J.L. (2010). The role of radiotherapy for metastatic epidural spinal cord compression. Nature Reviews Clinical Oncology 7,10:590-598. Sahgal, A. (2010). Spinal cord tolerance to radiation. Journal of Pain Management 4,1:99-104. Sahgal, A., Massicotte, E., Rampersaud, R., et al. (2010). Stereotactic body radiotherapy for spine tumors. Journal of Pain Management 4,1:33-42. Souchon, R., Feyer, P., Thomssen, C., et al. (2010). Clinical recommendations of DEGRO and AGO on preferred standard palliative radiotherapy of bone and cerebral metastases, metastatic spinal cord compression, and leptomeningeal carcinomatosis in breast cancer. Breast Care 5,6:401-407. Symptom Management & Supportive Care Body, J.-. (2010). Prevention and treatment of side-effects of systemic treatment: Bone loss. Annals of Oncology 21,SUPPL. 7:180-185. Chow, E., Presutti, R., Nguyen, J., et al. (2010). Bone metastases and quality of life. Journal of Pain Management 4,1:117-131. Lee, R.J., Saylor, P.J. and Smith, M.R. (2011). Treatment and prevention of bone 4 Sarcoma and Bone Cancers, January 2011 Kirsty Coltart, Specialist Librarian, NHSGGC Library Network complications from prostate cancer. Bone 48,1:88-95. Saad, F. and Eastham, J. (2010). Zoledronic Acid improves clinical outcomes when administered before onset of bone pain in patients with prostate cancer. Urology 76,5:1175-1181. Woodward, E., Jagdev, S., McParland, L., et al. (2011). Skeletal complications and survival in renal cancer patients with bone metastases. Bone 48,1:160-166. Surgery Dear, R.F. and Tattersal, M.H.N. (2010). Role of pulmonary metastasectomy in osteosarcoma and soft tissue sarcoma. Cancer Forum 34,3:149-153. Ghert, M., Algawahmed, H., Turcotte, R., et al. (2010). High-speed burring with and without the use of surgical adjuvants in the intralesional management of giant cell tumor of bone: A systematic review and meta-analysis. Sarcoma 2010, Vorgias, G. and Fotiou, S. (2010). The role of lymphadenectomy in uterine carcinosarcomas (malignant mixed mullerian tumours): A critical literature review. Archives of Gynecology and Obstetrics 282,6:659-664. Please note that the journal articles you are accessing may be protected by copyright legislation so there may be a limit on the number of articles you can download or print from any single issue of a journal. If you obtain a copy via your local library's document request service, you may be required to complete a copyright declaration form. Consult your local library with any queries, or for further information see the website of the Copyright Licensing Agency at www.cla.co.uk. If you have any questions regarding this or any other library services please contact Library staff – contact details are at the beginning of the bulletin. Sources used for this bulletin : OVID MEDLINE and MEDLINE in process, local journal collection 5 Sarcoma and Bone Cancers, January 2011 Kirsty Coltart, Specialist Librarian, NHSGGC Library Network